Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MD Anderson guides intelligent redesign of cancer care delivery model

06.02.2014
Quality leaders outline action plan for national oversight, collaboration and patient-centered approaches

How best to implement key recommendations recently identified by the Institute of Medicine (IOM) for the delivery of high-quality cancer care is the focus of two peer-reviewed articles from The University of Texas MD Anderson Cancer Center.

Published recently in Healthcare: The Journal of Delivery Science and Innovation and the Journal of the American Medical Informatics Association, the papers elaborate on recommendations in the September 2013 IOM report, Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis.

The papers support the ability to measure and improve national cancer care delivery systematically. Specifically, the papers' authors address two areas essential to improving the quality of cancer care in America, including the need to develop:

•A learning information technology (IT) system for cancer that enables real-time data analysis from cancer patients in a variety of care settings;

and

•A national quality reporting program for cancer care as a part of a learning health care system.

These needs embody key recommendations first brought to light in a 1999 IOM report on improving the quality of cancer care. Such intelligent systems provide patients and clinicians with the information and tools necessary to make well informed medical decisions, support quality measurement and improve care. With the nation's health care system undergoing rapid transformation precipitated by the Affordable Care Act, the widespread adoption of efforts that result in meaningful, patient-centric outcomes and costs of care are critical.

"It's time to pull back the curtain on cancer quality measurement efforts to date," said Thomas Feeley, M.D., director of MD Anderson's Institute for Cancer Care Innovation and an author on the papers. "Since the IOM recognized the need for a core set of quality measures to improve cancer care nearly 15 years ago, several organizations have made genuine attempts to fill these gaps. But their efforts lacked the breadth magnitude, coordination and sustainability to transform cancer care across the nation."

Potential leadership and management structure

In their analyses, Feeley and colleague, Tracy Spinks, project director of MD Anderson's Clinical Operations, call for federal oversight, ensuring the necessary level of leadership to direct, coordinate and fund nationwide quality efforts. The authors, who also served as contributors to the most recent IOM report, propose that this model would enforce key tasks for the intelligent redesign of cancer care delivery, among them:

Putting the Patient at the Center: Intelligent Redesign of the Cancer Care Delivery Model

Enlist the Centers for Medicare and Medicaid Services, the National Quality Forum and other professional organizations as key partners to align, unify and accelerate quality measurement efforts already underway.

Expand quality measures to include metrics that are meaningful to providers, payers and patients, with the highest priority given to those directly tied to outcomes. Fund health services research and clinical trials that elicit non-technical dimensions of quality cancer care and integrate the patient perspective.

Enhance health care IT systems by partnering with clinicians and the IT industry to collect and report standardized cancer metrics data so that it spurs innovation and improvement. An ideal system supports clinic workflow, powerful data analytics, real-time decision-making, care coordination and patient access.

Establish a public reporting procedure, that emphasizes transparency and that presents data in a way that guides patients and caregivers in their health care decision-making.

SOURCE: THE INSTITUTE FOR CANCER CARE INNOVATION AT THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER

The papers also address how important it is to include the perspective of elderly patients in metric development, as well as ensuring access to institutions that care for vulnerable and underserved populations. "The IOM provides a strong conceptual basis for these changes with the framework emerging from the report," Spinks said. "National coordination and funding will drive metrics that resonate with cancer patients, raising the bar beyond the safe and effective care that should be absolutes in our health care system. Ultimately, it will accelerate improvements in cancer care where other programs have failed."

Intelligent redesign in action

As the nation's largest cancer center with more than 32,000 new patients each year, MD Anderson is among the first to work toward identifying significant value-based outcomes for cancer patients and providers, through its Institute for Cancer Care Innovation.

The institute initiated its first comprehensive pilot project in 2008, collaborating with Michael E. Porter and the Harvard Business School. Their work in MD Anderson's Head and Neck Center resulted in a better understanding of what outcomes were important to patients and how best to gather and disseminate that information.

They're expanding this pilot to include patient focus groups for each multidisciplinary care center at the institution. This is the first phase of a two-year grant from the Arthur Vining Davis Foundation intended to narrow the outcomes that matter most to patients. The second phase, launching this year, will create a survey tool linked to MD Anderson's electronic health records that can better report patient outcomes and capture real-time patient needs.

Intelligent redesign is a concept first coined by Robert S. Kaplan of the Harvard Business School in a joint publication with the Institute for Cancer Care Innovation. MD Anderson is at the forefront of national and international efforts to reshape cancer care delivery so that it promotes value that is meaningful to patients, providers and insurers. Read more on the institute's initiatives underway in their latest newsletter.

Julie Penne | EurekAlert!
Further information:
http://www.mdanderson.org

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>